APA (7th ed.) Citation

Erwann P. Loret, Albert Darque, Elvenn A. Loret, Corinne Nicolino-Brunet, Sophie Morange, Elisabeth Castagnier, . . . Isabelle Ravaux. (2016). Intradermal injection of a Tat Oyi-based therapeutic HIV vaccine significantly reduces levels of HIV RNA and HIV DNA rebound following ART interruption in a phase I/II randomized controlled clinical trial. Elsevier.

Chicago Style (17th ed.) Citation

Erwann P. Loret, et al. Intradermal Injection of a Tat Oyi-based Therapeutic HIV Vaccine Significantly Reduces Levels of HIV RNA and HIV DNA Rebound Following ART Interruption in a Phase I/II Randomized Controlled Clinical Trial. Elsevier, 2016.

MLA (9th ed.) Citation

Erwann P. Loret, et al. Intradermal Injection of a Tat Oyi-based Therapeutic HIV Vaccine Significantly Reduces Levels of HIV RNA and HIV DNA Rebound Following ART Interruption in a Phase I/II Randomized Controlled Clinical Trial. Elsevier, 2016.